Sitagliptin (Januvia)

sitagliptin · Merck & Co.

Drug timelines are a Plus or Pro feature.

11 regulatory and trial events tracked for Sitagliptin (Januvia), covering 2009-07-31 to 2018-06-27. Get the full timeline:

Most recent: Clinical Trial Update: Sitagliptin in Non-Diabetic Patients Undergoing General Surgery [Phase 4]